Featured
Fine-Tuning Cancer Immunotherapy with Artificial
In a significant step toward improving immune-based therapies for cancer, a team of researchers from the National Institute of Immunology, India, has taken a leap forward in enhancing the body’s natural defenses using precision-engineered nanoparticles.
Status, stress and responses
Researchers at the BRIC-NII have unraveled a critical role of PARP1 enzyme in DNA damage response and metabolic homeostasis.
New drug candidates to overcome chemoresistance
Researchers identified three FDA-approved drugs that disrupt a key protein interaction, overcoming chemoresistance in colon cancer.
Latest News
Fine-Tuning Cancer Immunotherapy with Artificial
In a significant step toward improving immune-based therapies for cancer, a team of researchers from the National Institute of Immunology, India,
Status, stress and responses
Researchers at the BRIC-NII have unraveled a critical role of PARP1 enzyme in DNA damage response and metabolic homeostasis.
New drug candidates to overcome chemoresistance
Researchers identified three FDA-approved drugs that disrupt a key protein interaction, overcoming chemoresistance in colon cancer.